Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ISRCTN90482257) titled 'Understanding why cancer immunotherapy helps some people but causes side effects in others' on April 24.
Study Type: Observational
Study Design:
Cohort study
Primary Sponsor: The Christie NHS Foundation Trust
Condition:
Psychosocial oncology and survivorship
Cancer
Intervention:
MANIFEST is an observational research study. It will involve patients who are receiving immunotherapy as part of their planned cancer treatment at NHS hospitals - the study will not change or interfere with the care they receive. The aim is to collect and analyse samples and data that may help us better understand why some people bene...